These statements are not guarantees of future performance but rather are subject to a variety of risks and uncertainties ... as well as by leveraging other cutting-edge technologies and our data ...

Scammers tried to trick me again. And once again, their sophisticated methods surprised me, someone who sniffs out scams for ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new enterprise agreement with Bioforum, a biometrics CRO that ...

The next stage of AI battles could well see governments vying for superiority for better governance. Within that paradigm, AI ...

Concluded targeted enrollment of Phase 3 INDIGO trial evaluating obexelimab for the treatment of Immunoglobulin G4-Related ...

Q3 2024 Earnings Call Transcript November 7, 2024 EPAM Systems, Inc. beats earnings expectations. Reported EPS is $3.12, ...

Achieves 10% year-over-year revenue growth, record GAAP net income of $27.8 million and adjusted EBITDA of $43.2 millionThird-quarter GAAP ...

Ilan Sobel, Chief Executive Officer of BioHarvest Sciences, said: "Our Nasdaq listing is a monumental milestone in our corporate history, which we believe will serve to elevate our public profile in ...

The Conference of the Parties (COP) is the United Nation’s annual climate change gathering. The current edition is in Baku, ...

Logos Space aims to add another 4,000 satellites to the throng racing over our heads, delivering high speed data to ...

I was an average student with few ambitions to enter college. I got the push I needed from a fellow middle-schooler with a go ...

Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ ...